Proteome data of serum samples from patients with schizophrenia

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Schizophrenia is a complex chronic brain disorder with poorly understood molecular mechanisms.
• Dysregulation of molecular and epigenetic factors plays a role in schizophrenia pathogenesis.
• Identifying specific molecular markers is crucial for understanding and potentially treating schizophrenia.

Purpose of the Study:

• To investigate the proteomic differences in serum samples between individuals with schizophrenia and healthy controls.
• To contribute to the accumulation and systematization of "OMICS" data for schizophrenia research.
• To advance the understanding of molecular determinants in schizophrenia development.

Main Methods:

• Utilized shotgun ultra-high resolution mass spectrometry for proteomic analysis.
• Analyzed serum samples from patients diagnosed with schizophrenia (SCZ series).
• Compared proteomic data with serum samples from healthy volunteers (CNT series).

Main Results:

• Generated comprehensive proteomic datasets for schizophrenia patients and healthy controls.
• Established a foundation for identifying serological protein markers associated with schizophrenia.
• Highlighted the importance of mass spectrometry in detecting biological molecules for biomedical research.

Conclusions:

• The study provides valuable proteomic datasets for further research into schizophrenia.
• Advances the identification of potential protein biomarkers for schizophrenia.
• Emphasizes the role of OMICS approaches in unraveling complex disease mechanisms.